In vitro and in vivo antibacterial activities of S-1090, a new oral cephalosporin.
S-1090, a new oral cephalosporin, was active against selected gram-negative bacteria and methicillin-susceptible clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus warneri, against which it had excellent activity. S-1090 was the most active compound against St...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1995
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162981/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8585742/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.11.2544 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|